These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 25048725
41. The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer. Jiang F, Kuang B, Que Y, Lin Z, Yuan L, Xiao W, Peng R, Zhang X, Zhang X. Oncol Rep; 2016 Jan; 35(1):436-46. PubMed ID: 26531241 [Abstract] [Full Text] [Related]
44. TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients. Zhang X, Han S, Zhou H, Cai L, Li J, Liu N, Liu Y, Wang L, Fan C, Li A, Miao Y. Mol Carcinog; 2019 May; 58(5):767-776. PubMed ID: 30604908 [Abstract] [Full Text] [Related]
46. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer. Li J, Liu Y, Xue J, Xu M, Zhang J, Liu J, Wang W. Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741 [Abstract] [Full Text] [Related]
48. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis. Liu X, Huang G, Zhang J, Zhang L, Liang Z. PLoS One; 2020 Jan; 15(10):e0240321. PubMed ID: 33052949 [Abstract] [Full Text] [Related]
49. UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer. Zhao L, Jiang L, Wang L, He J, Yu H, Sun G, Chen J, Xiu Q, Li B. J Cancer Res Clin Oncol; 2012 Nov; 138(11):1951-61. PubMed ID: 22760214 [Abstract] [Full Text] [Related]
50. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer. Wang D, Hao T, Pan Y, Qian X, Zhou D. Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207 [Abstract] [Full Text] [Related]
52. Increased HSP27 correlates with malignant biological behavior of non-small cell lung cancer and predicts patient's survival. Sheng B, Qi C, Liu B, Lin Y, Fu T, Zeng Q. Sci Rep; 2017 Oct 23; 7(1):13807. PubMed ID: 29062135 [Abstract] [Full Text] [Related]
53. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer. Zhong KZ, Chen WW, Hu XY, Jiang AL, Zhao J. Int J Clin Exp Pathol; 2014 Oct 23; 7(7):4545-51. PubMed ID: 25120851 [Abstract] [Full Text] [Related]
55. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer. Liu J, Lin Y, Yang H, Deng Q, Chen G, He J. Tumour Biol; 2011 Dec 23; 32(6):1113-21. PubMed ID: 21779982 [Abstract] [Full Text] [Related]
56. Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer. Ye X, Ling B, Xu H, Li G, Zhao X, Xu J, Liu J, Liu L. Medicine (Baltimore); 2020 Apr 23; 99(16):e19755. PubMed ID: 32311975 [Abstract] [Full Text] [Related]